C.M. Bidwell & Associates’s Organogenesis Holdings ORGO Stock Holding History

C.M. Bidwell & Associates’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-157	Closed	-$575	–	520
2025 Q2	$575	Buy	+157	New	+$585	﹤0.01%	408
2021 Q3	–	Sell	-4,030	Closed	-$67K	–	599
2021 Q2	$67K	Sell	4,030 -105	-3%	-$1.96K	0.04%	275
2021 Q1	$75K	Buy	+4,135	New	+$56K	0.05%	265

Other funds holding ORGO

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

C.M. Bidwell & Associates's ORGO Position: Q3 2025 in Review

C.M. Bidwell & Associates sold out of Organogenesis Holdings (ORGO) in Q3 2025, closing a stake of 157 shares — an estimated $575 sold.

C.M. Bidwell & Associates first reported a position in ORGO in Q1 2021 and held it in 3 quarters. The position peaked at $75K in Q1 2021. 121 funds tracked by Wall St. Rank hold ORGO as of Q3 2025.

C.M. Bidwell & Associates reported no remaining Organogenesis Holdings position as of Q3 2025 after selling out during the quarter.
C.M. Bidwell & Associates sold 157 Organogenesis Holdings shares in Q3 2025, an estimated $575.
C.M. Bidwell & Associates first reported a position in Organogenesis Holdings in Q1 2021 and held it in 3 quarters.
C.M. Bidwell & Associates's Organogenesis Holdings position peaked at $75K in Q1 2021.
121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q3 2025.

Based on C.M. Bidwell & Associates's 13F filing for Q3 2025, filed 13 Nov 2025.